use
mathemat
model
abstract
complex
network
fig
illustr
mechan
condit
properti
oper
mathemat
model
base
system
ordinari
differenti
equat
use
order
incorpor
signal
network
simplifi
network
shown
fig
follow
merg
ampk
regulatori
network
ampkmark
one
compon
ampk
complex
middl
box
solid
line
fig
kept
mtor
dot
box
fig
separ
modul
mathemat
model
network
shown
fig
refer
interact
repres
edg
fig
core
control
system
convent
kinet
interpret
arrow
hammerhead
network
repres
induct
arrow
inhibit
hammerhead
let
variabl
r
activ
ampk
complex
mtor
respect
scheme
includ
autocatalyt
activ
ampk
complex
mtor
r
report
micrornaprotein
degrad
key
molecul
mutual
inhibit
ampk
complex
inhibit
mtor
activ
ampk
complex
base
biolog
observ
write
phenomenolog
equat
rate
chang
key
modul
r
follow
g
signal
rate
glucos
g
glucos
level
signal
pathway
ampk
complex
mtor
respect
autocatalyt
enhanc
paramet
ampk
complex
mtor
respect
hilltyp
inhibit
satur
paramet
counter
part
ampk
complex
mtor
respect
inhibit
strength
ampk
complex
inhibit
strength
ampk
complex
inhibit
strength
mtor
ampk
complex
final
micrornaprotein
degrad
rate
ampk
complex
mtor
respect
indic
eq
signal
g
increas
rate
activ
function
f
g
first
term
ampkdepend
inhibit
express
function
f
denomin
second
term
simpl
requir
function
nonneg
g
nonneg
similarli
first
term
h
righthand
side
eq
repres
increas
ampk
activ
induc
signal
suppress
ampk
activ
explor
function
h
denomin
manner
first
term
h
righthand
side
eq
repres
increas
mtor
activ
induc
signal
ampkdepend
suppress
mtor
activ
account
function
h
denomin
one
must
also
nonneg
base
biolog
observ
fig
assum
f
g
g
g
f
h
h
h
h
furthermor
perform
follow
nondimension
dimension
eq
obtain
associ
dimensionless
equat
smaller
set
essenti
control
paramet
name
dr
dt
r
paramet
estim
mirna
typic
stabl
target
typic
halflif
mirna
much
larger
ampk
mtor
lead
small
valu
fraction
estim
concentr
mirna
pm
anim
cell
assum
volum
take
normal
high
gl
low
gl
glucos
level
use
order
test
effect
glucos
express
ampk
activ
proliferationmigr
pattern
glioma
cell
use
rang
glucos
level
gl
refer
valu
determin
glucos
signal
strength
result
rang
dimensionless
glucos
input
level
g
g
use
refer
valu
ampk
taken
measur
valu
nm
rat
liver
take
signal
sourc
ampk
complex
nmh
estim
dimensionless
valu
signal
strength
ampk
complex
observ
pattern
upand
downregul
mtor
respons
variou
glucos
level
take
slightli
larger
valu
work
take
dimensionless
paramet
valu
assum
autocatalyt
rate
least
larger
neg
contribut
decayconsumpt
absenc
inhibitori
pathway
ampk
complex
reli
observ
mutual
antagon
ampk
complex
also
take
similar
fashion
hilltyp
coeffici
correspond
dimensionless
paramet
fix
uniti
paramet
determin
fit
data
level
activ
respons
neg
control
express
level
fig
follow
way
steadi
state
ampk
complex
term
level
paramet
model
rewritten
upregul
ampk
complex
level
pmol
phosphat
incorpor
dimension
form
neg
control
downregul
pmol
phosphat
incorpor
dimension
form
use
eq
estim
paramet
valu
give
low
ampk
complex
activ
respons
high
dimensionless
level
high
ampk
complex
activ
respons
neg
control
level
result
reason
differ
ampk
complex
activ
experi
final
observ
behavior
system
experiment
data
assum
inhibit
strength
ampk
complex
slightli
larger
inhibit
strength
ampk
complex
keep
valu
inhibit
strength
mtor
ampk
complex
analysi
core
control
system
character
migrat
prolifer
perturb
key
paramet
fig
show
sensit
variabl
core
control
system
respons
glucos
level
g
chang
inhibit
strength
ampk
complex
increas
bifurc
curv
variabl
ampk
mtor
shift
right
fig
overal
increas
also
move
bistabl
window
w
b
right
case
ampk
mtor
lead
decreas
size
window
w
b
also
illustr
fig
indic
probabl
switch
migrat
phase
increas
inhibit
strength
ampk
increas
exampl
cell
alreadi
migratori
phase
th
th
r
th
r
g
case
higher
still
prolif
phase
th
th
r
th
r
base
case
hand
glioma
cell
would
grow
even
glucos
withdraw
condit
decreas
exampl
cell
still
prolif
phase
th
th
r
th
r
low
glucos
level
g
lower
migratori
phase
th
th
r
th
r
base
case
fig
show
phase
diagram
g
switch
behavior
includ
monost
region
bistabl
oneway
switch
increas
inhibit
strength
ampk
induc
transit
oneway
switch
bistabl
switch
monost
decreas
increas
size
bistabl
window
w
b
recal
base
case
exist
bistabl
regim
illustr
glucos
regul
forward
transit
migratori
phenotyp
prolif
phenotyp
p
recurr
process
pstate
state
howev
activ
highli
enhanc
decreas
inhibit
signal
ampk
complex
decreas
glucos
may
regul
forward
transit
state
p
state
one
way
switch
monoton
decreas
glucos
push
cell
migratori
paramet
fix
tabl
base
case
mark
star
ac
e
phenotyp
chang
respons
glucos
level
g
key
inhibit
paramet
vari
phase
therefor
mechan
may
provid
way
keep
glioma
cell
prolif
phase
certain
period
time
order
prevent
invas
process
second
surgeri
phenotyp
chang
state
p
state
increas
decreas
illustr
fig
increas
decreas
gener
higher
probabl
switch
migratori
prolif
phenotyp
given
glucos
level
move
bifurc
curv
bistabl
window
w
b
right
left
fig
ad
show
effect
inhibit
strength
ampk
complex
dynam
core
control
system
increas
bifurc
curv
variabl
ampk
mtor
shift
left
fig
ac
contrast
case
chang
increas
revers
shift
direct
ie
move
bistabl
window
w
b
left
case
ampk
mtor
lead
increas
size
window
w
b
despit
disappear
bistabl
switch
also
illustr
fig
indic
probabl
switch
prolif
phase
increas
respons
fluctuat
glucos
level
g
inhibit
strength
ampk
increas
exampl
cell
alreadi
prolif
phase
th
th
r
th
r
g
case
higher
still
migratori
phase
th
th
r
th
r
base
case
hand
glioma
cell
would
initi
motil
machineri
even
normal
glucos
condit
decreas
exampl
cell
would
increas
probabl
switch
migratori
phase
lower
mtor
level
normal
glucos
level
g
lower
prolif
phase
th
th
r
th
r
base
case
fig
show
phase
diagram
g
switch
behavior
includ
monost
region
bistabl
oneway
switch
increas
inhibit
strength
ampk
induc
transit
bistabl
switch
oneway
switch
monost
decreas
reduc
size
bistabl
window
w
b
increas
reduc
size
oneway
switch
window
activ
highli
enhanc
increas
inhibit
signal
ampk
increas
due
mutual
antagon
ampk
glucos
may
also
regul
forward
transit
state
p
state
one
way
switch
monoton
decreas
glucos
push
cell
migratori
phase
therefor
mechan
similar
effect
keep
high
level
decreas
provid
way
keep
glioma
cell
prolif
phase
fig
summar
phenotyp
chang
p
group
vari
increas
decreas
lead
weaken
strengthen
ampk
modul
upregul
downregul
due
mutual
antagon
ampk
result
cell
prolifer
migrat
fig
illustr
effect
increas
decreas
inhibit
strength
mtor
activ
ampk
complex
regul
mtor
express
recal
cell
migrat
prolifer
heavili
depend
glucos
level
base
paramet
set
ie
upand
downregul
mtor
express
level
respons
high
low
glucos
level
g
howev
found
dynam
prolifer
migrat
chang
vari
increas
base
valu
mtor
activ
significantli
reduc
lead
underexpress
mtor
regardless
high
low
glucos
level
therefor
enhanc
inhibit
mtor
ampk
complex
induc
complet
block
mtor
activ
r
th
r
follow
cell
migrat
even
case
high
glucos
inject
hand
cell
migrat
may
inhibit
decreas
base
valu
exampl
mtor
level
stay
threshold
valu
th
r
even
low
glucos
level
g
exampl
mean
glioma
cell
may
stay
prolif
phase
respons
high
low
glucos
level
inhibit
mtor
ampk
complex
weaken
also
note
bifurc
curv
two
key
molecul
ampk
thu
bistabl
window
affect
chang
due
network
structur
signal
pathway
signal
pathway
fig
see
fig
correspond
phenotyp
chang
p
group
shown
case
increas
decreas
gener
higher
probabl
switch
migratori
prolif
phenotyp
given
glucos
level
lift
bifurc
curv
keep
bistabl
window
w
b
recal
system
exhibit
switch
behavior
increas
decreas
g
induc
transit
statu
p
statu
p
statu
statu
steadyst
mtor
bifurc
diagram
function
paramet
g
variou
valu
present
top
panel
fig
show
push
pull
properti
mtor
see
fig
ac
mtor
level
r
decreas
increas
fix
g
bifurc
curv
move
right
fix
seen
fig
system
exhibit
hysteresi
properti
bistabl
system
base
paramet
set
increas
variou
perturb
consid
howev
decreas
larger
valu
respons
switch
slightli
differ
exampl
core
control
system
lose
bistabl
properti
larger
fig
therefor
even
base
valu
case
increas
decreas
glucos
lead
smooth
transit
statu
p
statu
p
statu
mstatu
along
branch
howev
system
also
illustr
extrem
case
hysteresi
oneway
switch
increas
fig
upper
branch
p
regim
stretch
larger
domain
actual
need
elimin
due
physiolog
irrelev
regim
g
glucos
exampl
fig
base
fig
oneway
switch
case
glucos
withdraw
normal
level
would
induc
cell
migrat
main
tumor
mass
slow
suppli
glucos
complet
withdraw
condit
would
put
glioma
cell
mand
p
statu
depend
initi
condit
variabl
r
core
control
system
tabl
correspond
profil
bifurc
curv
r
function
glucos
level
g
differ
bistabl
area
enclos
two
saddlenod
bifurc
point
right
left
knee
curv
top
panel
fig
glucos
level
bistabl
window
system
two
stabl
solut
one
unstabl
solut
saw
basic
paramet
set
fig
bottom
panel
fig
show
phase
diagram
switch
behavior
includ
monost
region
bistabl
oneway
switch
differ
valu
three
case
increas
inhibit
strength
induc
transit
oneway
switch
bistabl
switch
monost
increas
autocatalyt
product
rate
result
increas
size
oneway
bistabl
region
g
plane
also
move
bistabl
switch
region
therefor
increas
valu
creat
rich
dynam
mixtur
oneway
switch
bistabl
switch
monost
core
control
system
thu
complex
phenotyp
switch
p
type
top
panel
fig
present
steadyst
mtor
bifurc
diagram
function
glucos
level
g
variou
valu
mtor
level
r
decreas
increas
fix
g
increas
autocatalyt
product
rate
ampk
fig
push
bifurc
curv
right
fix
increas
probabl
establish
phenotyp
r
th
r
shown
fig
increas
caus
overal
shift
left
curv
lead
higher
chanc
acquir
p
phenotyp
core
control
system
lose
bistabl
properti
lead
oneway
switch
decreas
therefor
effect
cell
fate
decreas
fig
ie
glucos
withdraw
guarante
initi
glioma
cell
migrat
main
tumor
core
glucos
suppli
zero
level
may
gener
p
phenotyp
depend
initi
condit
key
molecul
ampk
mtor
core
control
system
bottom
panel
fig
show
phase
diagram
switch
behavior
includ
monost
region
bistabl
oneway
switch
differ
three
case
increas
induc
transit
oneway
switch
bistabl
switch
monost
increas
lead
increas
size
oneway
bistabl
region
g
plane
also
move
bistabl
switch
region
therefor
increas
valu
creat
richer
dynam
larger
rang
mixtur
oneway
switch
bistabl
switch
monost
core
control
system
thu
complex
phenotyp
switch
p
type
model
develop
paper
number
paramet
experiment
data
known
andor
may
signific
effect
result
consid
paramet
g
sensit
analysi
core
control
model
order
determin
sensit
main
variabl
level
ampk
activ
mtor
activ
model
certain
time
paramet
perform
sensit
analysi
chosen
rang
paramet
divid
rang
interv
uniform
length
fourteen
paramet
interest
partial
rank
correl
coeffici
prcc
valu
calcul
prcc
valu
rang
sign
determin
whether
increas
paramet
valu
decreas
increas
level
ampk
activ
mtor
activ
given
time
sensit
analysi
describ
carri
use
method
matlab
file
avail
websit
denis
kirschner
lab
http
malthusmicromedumichedulabusadata
fig
show
sensit
analysi
result
level
ampk
activ
mtor
activ
b
calcul
prcc
valu
associ
pvalu
fourteen
perturb
paramet
g
g
model
ie
comput
prcc
valu
level
ampk
activ
mtor
activ
time
conclud
level
posit
correl
paramet
g
poorli
correl
thu
sensit
thu
particular
mir
tabl
indic
prcc
valu
level
ampk
activ
mtor
activ
model
paramet
g
g
b
analysi
carri
use
method
sampl
size
activ
increas
significantli
glucos
signal
g
autocatalyt
product
rate
increas
hand
activ
neg
correl
paramet
ie
would
signific
decreas
level
signal
ampk
complex
inhibit
strength
ampk
complex
increas
due
mutual
antagon
level
ampk
activ
expect
see
opposit
correl
ampk
activ
paramet
inde
ampk
activ
posit
correl
paramet
neg
correl
glucos
signal
g
inhibit
paramet
ampk
ampk
activ
sensit
paramet
due
structur
model
might
expect
see
sensit
mtor
activ
paramet
sensit
level
howev
mtor
activ
posit
correl
paramet
poorli
correl
g
hand
mtor
activ
neg
correl
signal
strength
ampk
complex
inhibit
strength
mtor
ampk
complex
due
strong
inhibitori
effect
lkbampk
mtor
test
effect
intervent
three
pathway
regul
cell
migrat
prolifer
assum
glucos
deliv
glioma
cell
blood
vessel
nearbi
ii
drug
inject
either
intraven
via
simpl
inject
directli
site
purpos
introduc
two
equat
glucos
g
drug
g
consumpt
rate
glucos
brain
tissu
natur
decay
rate
drug
g
extern
period
sourc
glucos
blood
vessel
time
interv
h
g
n
g
time
durat
h
period
g
n
g
h
g
g
interv
n
g
number
glucos
inject
indic
function
similar
fashion
extern
period
sourc
drug
time
interv
j
j
h
j
n
time
durat
h
period
j
j
n
h
interv
n
number
drug
inject
fig
show
effect
inhibit
ampk
complex
drug
eq
consid
modifi
equat
effect
inhibitori
drug
pathway
eq
coupl
core
control
system
fig
effect
domin
prolifer
mode
obtain
block
inhibit
pathway
mtor
ampk
complex
ie
fig
result
indic
possibl
strategi
either
increas
decreas
cell
migrat
molecular
level
instanc
kim
et
al
suggest
therapeut
strategi
use
core
control
system
term
local
invas
cell
immedi
first
surgeri
follow
secondari
surgeri
remov
local
invas
cell
peripheri
origin
surgic
site
optim
control
theori
also
appli
strategi
order
obtain
optim
solut
maintain
noninvas
statu
given
glucos
constraint
sinc
much
glucos
could
lead
clinic
complic
especi
diabet
patient
glioblastoma
ampk
stimul
inhibit
could
lead
better
clinic
outcom
differ
type
stage
cancer
instanc
author
report
stimul
ampk
pharmacolog
compound
may
induc
antitumor
effect
experi
especi
diabet
type
ii
patient
antidiabet
drug
metformin
toxic
malign
tumor
cell
howev
activ
ampk
provid
better
chanc
surviv
mani
type
cancer
instanc
ampk
play
central
role
overcom
anoiki
program
cell
death
loss
attach
basement
membran
ampk
also
central
coordin
metabol
reprogram
known
warburg
effect
hallmark
malign
tumor
cell
ampk
inhibit
rather
promot
may
repres
potenti
therapeut
strategi
glioblastoma
activ
infiltr
undetect
cancer
cell
lead
final
recurr
poor
clinic
outcom
exampl
compound
c
revers
atpcompetit
ampk
inhibitor
use
inhibit
ampk
glioma
cell
expos
highli
heterogen
microenviron
fluctuat
glucos
level
experiment
clear
mani
pathway
fast
action
necessari
order
induc
inhibitori
action
ampk
complex
consid
two
time
delay
inhibit
pathway
inhibit
ampk
complex
ii
inhibit
ampk
complex
fig
test
effect
time
delay
inhibit
pathway
regul
cell
migrat
prolifer
use
follow
modifi
delay
differenti
equat
dde
time
rescal
usingt
comput
conveni
directli
act
ampk
complex
inhibit
ampk
complex
involv
indirect
regul
via
mani
pathway
lead
delay
inhibit
ampk
complex
intervent
direct
action
ampk
complex
also
induc
time
delay
differ
combin
two
time
delay
inhibit
strength
lead
divers
behavior
term
cell
migrat
prolifer
fig
investig
effect
time
delay
regul
cell
migrat
prolifer
respons
intermedi
glucos
level
g
model
predict
tumor
cell
adapt
prolif
mode
threshold
fig
cell
switch
migratori
phase
threshold
figur
two
time
delay
small
system
lead
either
prolif
migratori
phase
depend
rel
strength
fig
note
cell
migratori
phase
initi
condit
r
absenc
time
delay
ie
fig
hand
system
lead
oscil
p
rel
larg
exampl
fig
result
indic
difficulti
treatment
gbm
presenc
time
delay
microenviron
glucos
may
fluctuat
ie
possibl
drug
target
ampk
inhibit
may
work
heterogen
glioma
popul
altern
strategi
may
need
develop
stochast
fluctuat
signal
network
mirna
may
play
signific
role
regul
cell
fate
fig
illustr
stochast
effect
ampk
complex
downstream
mtor
activ
regul
cell
migrat
respons
fluctuat
glucos
g
sin
level
fig
show
one
realiz
perturb
activ
fig
ampk
complex
fig
g
g
plane
respect
time
cours
mtor
level
fig
gray
curv
fig
repres
bifurc
curv
absenc
nois
fig
system
show
period
oscil
mtor
level
p
phase
absenc
nois
green
solid
line
maintain
p
phase
first
cycl
interv
arrow
fig
nois
chanc
infiltr
glioma
cell
posit
correl
time
spent
phase
increas
risk
tumor
recurr
fig
show
risk
map
without
fig
fig
nois
variou
combin
respons
fluctuat
glucos
nois
fig
ac
overal
pattern
high
risk
smaller
larger
fig
similar
case
nois
fig
intermedi
boundari
area
p
larger
fig
word
cell
migrat
subject
stochast
nois
ampk
pathway
final
fig
show
time
cours
mtor
activ
nois
inhibit
mtor
activ
ampk
complex
variou
red
green
blue
found
core
control
system
highli
adapt
term
select
p
phase
even
perturb
mtor
inhibit
mirna
recent
emerg
one
key
regul
cellular
process
cell
cycl
despit
recent
breakthrough
knowledg
mirna
clear
yet
mani
mirna
figur
stochast
effect
behavior
core
system
respons
fluctuat
glucos
level
g
sin
ampk
level
perturb
random
gaussian
input
ad
righthand
side
eq
b
standard
brownian
motion
ac
one
realiz
stochast
simul
trajectori
g
g
plane
b
correspond
time
cours
mtor
activ
c
shown
red
gray
bifurc
curv
without
nois
shown
b
green
curv
repres
trajectori
b
time
cours
c
absenc
nois
respons
glucos
withdraw
system
stay
p
phase
nois
arrow
switch
phase
shade
light
blue
box
without
nois
green
curv
paramet
tabl
involv
regul
cancer
progress
mirna
exactli
control
cellular
process
tumor
growth
overal
upregul
mirna
brain
tumor
believ
play
pivot
role
prooncogen
activ
support
growth
prolifer
migrat
surviv
cancer
cell
express
mirna
suppress
glioma
mirna
harbor
clinic
signific
therapeut
compon
anticanc
therapi
ampk
mtor
one
master
player
metabol
reprogram
glioma
godlewski
et
al
identifi
key
molecular
control
system
ampk
complex
mtor
provid
critic
switch
cell
prolifer
migrat
found
glucos
regul
glioma
cell
prolifer
migrat
via
core
control
system
low
glucos
downregul
upregul
ampk
complex
downregul
mtor
cell
migrat
ii
normal
high
glucos
upregul
downregul
ampk
complex
upregul
mtor
prolifer
develop
mathemat
model
core
control
system
base
experiment
observ
analyz
model
behavior
respons
high
low
glucos
level
respons
core
control
system
variou
glucos
level
good
agreement
experiment
result
particular
upand
downregul
mtor
respons
high
low
glucos
level
respect
ii
downand
upregul
ampk
complex
respons
normal
low
glucos
allow
us
defin
migratori
prolif
phase
base
statu
molecul
hysteresi
system
gener
bistabl
window
w
b
fig
predict
previou
smaller
model
model
system
predict
oneway
bistabl
monost
switch
perturb
key
inhibit
paramet
fig
fig
fig
phenotyp
chang
perturb
paramet
enabl
us
predict
p
statu
glioma
cell
glucos
fluctuat
microenviron
specif
compon
signal
system
perturb
exampl
drug
fig
chang
size
locat
bistabl
oneway
region
g
plane
perturb
inhibit
enhanc
paramet
also
gener
rich
dynam
cell
fate
migrat
prolifer
critic
depend
sign
dgdt
decreas
glucos
steadi
glucos
withdraw
consumpt
increas
glucos
suppli
blood
vessel
bv
glucos
intraven
infus
initi
condit
fig
also
investig
system
respons
perturb
inhibit
enhanc
paramet
ampk
complex
fig
onset
p
phenotyp
respons
drug
target
inhibit
pathway
ampk
complex
presenc
fluctuat
glucos
sensit
durat
strength
drug
p
phenotyp
select
drug
target
inhibit
pathway
mtor
fig
also
illustr
difficulti
treat
gbm
presenc
time
delay
inhibit
signal
network
due
divers
respons
gbm
cell
prolifer
migrat
period
chang
p
phase
fig
order
erad
heterogen
glioma
popul
altern
strategi
may
need
develop
instanc
precondit
chemotaxisdriven
local
cell
convent
surgeri
might
way
homogen
tumor
popul
order
increas
efficaci
drug
clinic
outcom
case
optim
solut
need
obtain
control
core
control
system
growth
pattern
gbm
determin
base
perivascular
accumul
cancer
cell
perineuron
satellitosi
subpial
growth
intrafascicular
growth
corpu
callosum
level
upregul
near
blood
vessel
due
high
level
glucos
suppli
glucos
level
stiff
brain
tissu
irregular
due
heterogen
microenviron
mani
microenvironment
factor
addit
intrins
nois
vast
signal
network
includ
system
may
introduc
biochem
perturb
within
core
control
system
cell
may
select
prolif
phase
instead
migratori
phase
even
glucos
condit
favor
migrat
fig
cancer
cell
within
tumor
exist
distinct
phenotyp
state
stochast
individu
behavior
may
promot
phenotyp
equilibrium
affect
transit
